55
Participants
Start Date
March 31, 1998
Primary Completion Date
March 31, 1999
Study Completion Date
March 31, 1999
chemotherapy
gemtuzumab ozogamicin
New York Presbyterian Hospital - Cornell Campus, New York
Long Island Jewish Medical Center, New Hyde Park
University of Pennsylvania Cancer Center, Philadelphia
Barbara Ann Karmanos Cancer Institute, Detroit
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
University of Chicago Cancer Research Center, Chicago
Arizona Cancer Center, Tucson
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
New England Medical Center Hospital, Boston
State University of New York Health Sciences Center - Stony Brook, Stony Brook
Lead Sponsor
Pfizer
INDUSTRY